Groopman J D, Zhu J Q, Donahue P R, Pikul A, Zhang L S, Chen J S, Wogan G N
Department of Environmental Health Sciences, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland 21205.
Cancer Res. 1992 Jan 1;52(1):45-52.
Hepatocellular carcinoma is one of the five leading human cancers causing at least 250,000 deaths each year. One of the major risk factors for this disease is exposure to dietary aflatoxins, and the development of appropriate molecular dosimetry biomarkers would facilitate the identification of individuals at risk. This study was undertaken to explore the relationship between dietary intake of aflatoxins and the excretion of the major aflatoxin-DNA adduct and other metabolites into the urine of chronically exposed people. The following protocol was developed for this investigation in Guangxi Autonomous Region, People's Republic of China, where the diets of 30 males and 12 females (ages, 25-64 years) were monitored for 1 week and aflatoxin intake levels determined each day. Starting on the fourth day, total urine volumes were obtained in consecutive 12-h fractions for 3 or 4 days. High performance liquid chromatography and competitive radioimmunoassay analyses were done on each of the urine samples, and the relationships between excretion of total aflatoxin metabolites, aflatoxin-N7-guanine, aflatoxin M1, aflatoxin P1, and aflatoxin B1, and aflatoxin B1 intake values were determined. The average intake of aflatoxin B1 by men was 48.4 micrograms/day, giving a total mean exposure during the study period of 276.8 micrograms. The average daily intake by women was 77.4 micrograms/day, resulting in a total average exposure during the 7-day period of 542.6 micrograms aflatoxin B1. Initial efforts to characterize aflatoxin metabolites in urine samples were with an analysis by competitive radioimmunoassay. The analysis by linear regression of the association between aflatoxin B1 intake/day and total aflatoxin metabolite excretion/day showed a correlation coefficient of only 0.26. These findings stimulated the immunoaffinity/analytical high performance liquid chromatography analysis for individual metabolites. When the data were analyzed by linear regression analysis, the aflatoxin N7-guanine excretion and aflatoxin B1 intake from the previous day showed a correlation coefficient of 0.65 and P less than 0.000001. Similar analysis for aflatoxin M1 resulted in a correlation coefficient of 0.55 and P less than 0.00001, whereas there was no positive statistical association between exposure in the diet and aflatoxin P1 excretion, despite aflatoxin P1 being quantitatively a major metabolite. Analysis of the total aflatoxin-N7-guanine excretion in the urine during the complete collection period plotted against the total aflatoxin B1 exposure in the diet for each of the individuals, smoothing the day to day variations, revealed a correlation coefficient of 0.80 and P less than 0.0000001.(ABSTRACT TRUNCATED AT 400 WORDS)
肝细胞癌是导致每年至少25万人死亡的五大主要人类癌症之一。这种疾病的主要风险因素之一是接触膳食黄曲霉毒素,开发合适的分子剂量生物标志物将有助于识别有风险的个体。本研究旨在探讨膳食黄曲霉毒素摄入量与长期接触者尿液中主要黄曲霉毒素 - DNA加合物及其他代谢物排泄之间的关系。在中国广西壮族自治区开展了以下调查方案,对30名男性和12名女性(年龄25 - 64岁)的饮食进行了1周监测,并确定每天的黄曲霉毒素摄入量。从第四天开始,连续3或4天每12小时收集一次总尿量。对每个尿液样本进行高效液相色谱和竞争性放射免疫分析,并确定总黄曲霉毒素代谢物、黄曲霉毒素 - N7 - 鸟嘌呤、黄曲霉毒素M1、黄曲霉毒素P1和黄曲霉毒素B1的排泄与黄曲霉毒素B1摄入量之间的关系。男性黄曲霉毒素B1的平均摄入量为48.4微克/天,在研究期间的总平均暴露量为276.8微克。女性的平均每日摄入量为77.4微克/天,在7天期间黄曲霉毒素B1的总平均暴露量为542.6微克。最初对尿液样本中黄曲霉毒素代谢物进行表征的努力是通过竞争性放射免疫分析。黄曲霉毒素B1每日摄入量与总黄曲霉毒素代谢物每日排泄量之间的线性回归分析显示相关系数仅为0.26。这些发现促使对个体代谢物进行免疫亲和/分析高效液相色谱分析。当通过线性回归分析数据时,前一天的黄曲霉毒素N7 - 鸟嘌呤排泄量与黄曲霉毒素B1摄入量的相关系数为0.65,P值小于0.000001。对黄曲霉毒素M1的类似分析得出相关系数为0.55,P值小于0.00001,尽管黄曲霉毒素P1在数量上是主要代谢物,但饮食暴露与黄曲霉毒素P1排泄之间没有正的统计学关联。对每个个体在整个收集期间尿液中总黄曲霉毒素 - N7 - 鸟嘌呤排泄量与饮食中总黄曲霉毒素B1暴露量进行分析,平滑每日变化,相关系数为0.80,P值小于0.0000001。(摘要截断于400字)